Opinion

Video

The Role of Testing for C Difficile in Clinical Practice

Key Takeaways

  • Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure.
  • Early testing facilitates prompt diagnosis and management, influencing treatment initiation timing.
SHOW MORE

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors such as recent antibiotic use, hospitalization, or older age, and how empiric treatment should be initiated while awaiting test results if there is high clinical suspension.

Video content above is prompted by the following:

  • In which patients do you test for C difficile before treating?
  • Does the timing of the testing influence when you start treatment?
Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo